Predicting Absorption-Distribution Properties of Neuroprotective Phosphine-Borane Compounds Using In Silico Modeling and Machine Learning
Source check: Source checked. Not independent scientific confirmation.
Finding: Machine-learning and in-silico models estimated absorption/distribution properties of phosphine-borane compounds from lipid, permeability and related features. The neural networks predicted properties of known boron-containing compounds; pharmacokinetic and clinical validation of new candidates was not established.
Technology: In-silico machine-learning/QSAR models predict absorption-distribution properties of phosphine-borane compounds.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- In-silico machine-learning/QSAR models predict absorption-distribution properties of phosphine-borane compounds.
- Test and result
- Neural-network and in-silico models predicted pharmacokinetic properties of known boron-containing compounds, including phosphine-borane candidates.
- Limitation / still unknown
- Predictions for known compounds do not establish experimental pharmacokinetics for newly proposed candidates or clinical efficacy.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://mdpi-res.com/d_attachment/molecules/molecules-26-02505/article_deploy/molecules-26-02505.pdf · https://pubmed.ncbi.nlm.nih.gov/33923006/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.